Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women

Aims. Whether or not cannabis use may increase or decrease the risk of type 2 diabetes is not clear. We analyzed the association between cannabis and subsequent type 2 diabetes and if a potential positive or reverse association persisted after controlling for potential confounders. Methods. In this...

Full description

Saved in:
Bibliographic Details
Main Authors: A. K. Danielsson, A. Lundin, A. Yaregal, C. G. Östenson, P. Allebeck, E. E. Agardh
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2016/6278709
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558306807250944
author A. K. Danielsson
A. Lundin
A. Yaregal
C. G. Östenson
P. Allebeck
E. E. Agardh
author_facet A. K. Danielsson
A. Lundin
A. Yaregal
C. G. Östenson
P. Allebeck
E. E. Agardh
author_sort A. K. Danielsson
collection DOAJ
description Aims. Whether or not cannabis use may increase or decrease the risk of type 2 diabetes is not clear. We analyzed the association between cannabis and subsequent type 2 diabetes and if a potential positive or reverse association persisted after controlling for potential confounders. Methods. In this population-based cohort study, 17,967 Swedish men and women (aged 18–84 years), who answered an extensive questionnaire in 2002 (including questions on cannabis use), were followed up for new cases of type 2 diabetes (n=608) by questionnaire (in 2010) and in health registers during 2003–2011. Odds ratios (ORs) with 95% CIs were estimated in a multiple logistic regression analysis. Potential confounders included age, sex, BMI, physical inactivity, smoking, alcohol use, and occupational position. Results. The crude association showed that cannabis users had a reduced risk of type 2 diabetes OR = 0.68 (95% CIs: 0.47–0.99). However, this inverse association attenuated to OR = 0.94 (95% CIs: 0.63–1.39) after adjusting for age. Conclusions. The present study suggests that there is no association between cannabis use and subsequent type 2 diabetes after controlling for age. To make more robust conclusions prospective studies, with longer periods of follow-up and more detailed information about cannabis use, are needed.
format Article
id doaj-art-3d76c36cd3df4f338b23be5766e5300a
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-3d76c36cd3df4f338b23be5766e5300a2025-02-03T01:32:37ZengWileyJournal of Diabetes Research2314-67452314-67532016-01-01201610.1155/2016/62787096278709Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and WomenA. K. Danielsson0A. Lundin1A. Yaregal2C. G. Östenson3P. Allebeck4E. E. Agardh5Department of Public Health Sciences, Karolinska Institutet, Stockholm, SwedenDepartment of Public Health Sciences, Karolinska Institutet, Stockholm, SwedenDepartment of Public Health Sciences, Karolinska Institutet, Stockholm, SwedenDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, SwedenDepartment of Public Health Sciences, Karolinska Institutet, Stockholm, SwedenDepartment of Public Health Sciences, Karolinska Institutet, Stockholm, SwedenAims. Whether or not cannabis use may increase or decrease the risk of type 2 diabetes is not clear. We analyzed the association between cannabis and subsequent type 2 diabetes and if a potential positive or reverse association persisted after controlling for potential confounders. Methods. In this population-based cohort study, 17,967 Swedish men and women (aged 18–84 years), who answered an extensive questionnaire in 2002 (including questions on cannabis use), were followed up for new cases of type 2 diabetes (n=608) by questionnaire (in 2010) and in health registers during 2003–2011. Odds ratios (ORs) with 95% CIs were estimated in a multiple logistic regression analysis. Potential confounders included age, sex, BMI, physical inactivity, smoking, alcohol use, and occupational position. Results. The crude association showed that cannabis users had a reduced risk of type 2 diabetes OR = 0.68 (95% CIs: 0.47–0.99). However, this inverse association attenuated to OR = 0.94 (95% CIs: 0.63–1.39) after adjusting for age. Conclusions. The present study suggests that there is no association between cannabis use and subsequent type 2 diabetes after controlling for age. To make more robust conclusions prospective studies, with longer periods of follow-up and more detailed information about cannabis use, are needed.http://dx.doi.org/10.1155/2016/6278709
spellingShingle A. K. Danielsson
A. Lundin
A. Yaregal
C. G. Östenson
P. Allebeck
E. E. Agardh
Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women
Journal of Diabetes Research
title Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women
title_full Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women
title_fullStr Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women
title_full_unstemmed Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women
title_short Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women
title_sort cannabis use as risk or protection for type 2 diabetes a longitudinal study of 18 000 swedish men and women
url http://dx.doi.org/10.1155/2016/6278709
work_keys_str_mv AT akdanielsson cannabisuseasriskorprotectionfortype2diabetesalongitudinalstudyof18000swedishmenandwomen
AT alundin cannabisuseasriskorprotectionfortype2diabetesalongitudinalstudyof18000swedishmenandwomen
AT ayaregal cannabisuseasriskorprotectionfortype2diabetesalongitudinalstudyof18000swedishmenandwomen
AT cgostenson cannabisuseasriskorprotectionfortype2diabetesalongitudinalstudyof18000swedishmenandwomen
AT pallebeck cannabisuseasriskorprotectionfortype2diabetesalongitudinalstudyof18000swedishmenandwomen
AT eeagardh cannabisuseasriskorprotectionfortype2diabetesalongitudinalstudyof18000swedishmenandwomen